A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

NCT01122368 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycoses

Interventions

DRUG: micafungin
DRUG: placebo

Sponsor

Astellas Pharma Inc